Stay updated on Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial page.

Latest updates to the Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial page
- Check5 days agoChange DetectedThe page revision label changed from Revision: v3.6.4 to Revision: v3.6.5, indicating a new page version. This is a maintenance update that does not alter the study information.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page revision was updated to v3.6.4 from v3.6.3, indicating a small update to the page's content/UI.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedRevision: v3.6.3 was introduced, replacing the previous v3.6.2. This represents a minor update to the page's software/template rather than changes to the study details.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2. This signals a deployment patch that likely includes internal fixes or minor updates to the page's infrastructure without altering visible study content.SummaryDifference0.1%

- Check63 days agoChange DetectedNew navigation/help links were added: Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, and How to Join a Study. The label Intervention / Treatment was reformatted to Intervention/Treatment, and the revision tag updated from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check70 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, indicating an updated version of the page.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial page.